Literature DB >> 21865432

Evaluation of the DiversiLab typing method in a multicenter study assessing horizontal spread of highly resistant gram-negative rods.

I T M A Overdevest1, I Willemsen, S Elberts, C Verhulst, M Rijnsburger, P Savelkoul, J A J W Kluytmans.   

Abstract

The worldwide prevalence of highly resistant Gram-negative rods (HR-GNR) is increasing rapidly. Reliable typing methods are needed to detect and control outbreaks and to monitor the effectiveness of infection control programs in endemic situations. In this study, we investigated the performance of the DiversiLab typing method in comparison with the amplified fragment length polymorphism (AFLP) typing method. Six hundred fifty-three HR-GNR isolates, which were obtained during a 6-month prospective survey in 18 Dutch hospitals, were typed by AFLP and DiversiLab. Subsequently, the sensitivity and specificity of DiversiLab were calculated, using AFLP as the reference method. In addition, results were compared by means of epidemiological linkage, and Cohen's kappa for agreement was calculated. DiversiLab considered significantly more isolates (275) to belong to a cluster than AFLP (198) (P < 0.001). In direct comparison, the sensitivity was 83.8%, and the specificity was 78.6%. When epidemiological linkage was included in the analysis, DiversiLab considered eight isolates as secondary cases, which were considered unique in AFLP. Only two secondary cases, according to AFLP, were missed by DiversiLab. This results in a kappa for agreement of 0.985. In daily practice, a typing method has to be used in combination with epidemiological information. When this was done, DiversiLab was shown to be a reliable method for the typing of HR-GNR. This, in combination with the ease of use and the speed, makes DiversiLab an appropriate method for screening in routine clinical practice. When a cluster is suspected and the consequences of these findings are substantial, a confirmatory analysis should be performed.

Entities:  

Mesh:

Year:  2011        PMID: 21865432      PMCID: PMC3187329          DOI: 10.1128/JCM.00605-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  Amplified-fragment length polymorphism analysis: the state of an art.

Authors:  P H Savelkoul; H J Aarts; J de Haas; L Dijkshoorn; B Duim; M Otsen; J L Rademaker; L Schouls; J A Lenstra
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

Review 2.  Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO).

Authors:  M F Q Kluytmans-Vandenbergh; J A J W Kluytmans; A Voss
Journal:  Infection       Date:  2005-10       Impact factor: 3.553

3.  Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines.

Authors:  Larry J Strausbaugh; Jane D Siegel; Robert A Weinstein
Journal:  Clin Infect Dis       Date:  2006-02-09       Impact factor: 9.079

Review 4.  Resistance in gram-negative bacteria: Enterobacteriaceae.

Authors:  David L Paterson
Journal:  Am J Infect Control       Date:  2006-06       Impact factor: 2.918

5.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

Authors:  D J Austin; K G Kristinsson; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

6.  Evaluation of the DiversiLab system for detection of hospital outbreaks of infections by different bacterial species.

Authors:  A C Fluit; A M Terlingen; L Andriessen; R Ikawaty; R van Mansfeld; J Top; J W Cohen Stuart; M A Leverstein-van Hall; C H E Boel
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

7.  Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study).

Authors:  I Willemsen; S Elberts; C Verhulst; M Rijnsburger; M Filius; P Savelkoul; J Kluytmans; E Lommerse; L Spanjaard; B Vlaminckx; A Vos; M Wulf; M Vos; R Wintermans; G Andriesse; J van Zeijl; E van der Vorm; A Buiting; P Sturm; H Blok; A Troelstra; A Kaiser; C Vandenbroucke-Grauls
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

8.  Reliability of Pseudomonas aeruginosa semi-automated rep-PCR genotyping in various epidemiological situations.

Authors:  A Doléans-Jordheim; B Cournoyer; E Bergeron; J Croizé; H Salord; J André; M-A Mazoyer; F N R Renaud; J Freney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-16       Impact factor: 3.267

9.  Use of automated repetitive-sequence-based PCR for rapid laboratory confirmation of nosocomial outbreaks.

Authors:  A J Grisold; G Zarfel; V Strenger; G Feierl; E Leitner; L Masoud; M Hoenigl; R B Raggam; V Dosch; E Marth
Journal:  J Infect       Date:  2009-10-29       Impact factor: 6.072

  9 in total
  4 in total

1.  Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.

Authors:  Branka Bedenić; Nataša Firis; Vesna Elveđi-Gašparović; Marija Krilanović; Krešimir Matanović; Iva Štimac; Josefa Luxner; Jasmina Vraneš; Tomislav Meštrović; Gernot Zarfel; Andrea Grisold
Journal:  Wien Klin Wochenschr       Date:  2016-05-25       Impact factor: 1.704

2.  Multilocus sequence typing of the porcine and human gastric pathogen Helicobacter suis.

Authors:  Jungang Liang; Richard Ducatelle; Frank Pasmans; Annemieke Smet; Freddy Haesebrouck; Bram Flahou
Journal:  J Clin Microbiol       Date:  2013-01-09       Impact factor: 5.948

Review 3.  Methicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology.

Authors:  Sahreena Lakhundi; Kunyan Zhang
Journal:  Clin Microbiol Rev       Date:  2018-09-12       Impact factor: 26.132

Review 4.  Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology.

Authors:  Christopher D Sibley; Gisele Peirano; Deirdre L Church
Journal:  Infect Genet Evol       Date:  2012-02-09       Impact factor: 3.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.